FCGRT and non-small cell lung carcinoma: Multivariate Cox regression analysis, adjusted for significant clinicopathological variables, identified FCGRT mRNA expression in the cancerous tissues as an independent indicator of favorable prognosis for NSCLC patients (HR = 0.332, 95% CI = 0.112 – 0.983, P = 0.047) (Table 1).